Results 211 to 220 of about 418,528 (398)

Metformin Treatment in PCOS Pregnancies Reduces Maternal Infections and Increases the Risk of Allergies and Eczema in the Offspring: Post Hoc Analyses of Two Randomised Controlled Trials and One Follow‐Up Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To evaluate the effect of metformin on immunological outcomes in pregnant women with polycystic ovary syndrome (PCOS) and their offspring. Design Post hoc analyses of two randomised controlled trials (PregMet and PregMet2) and one follow‐up study (PedMet).
Mariell Ryssdal, Johanne E. Skage, Anders H. Jarmund, Liv Guro E. Hanem, Tone S. Løvvik, Guro F. Giskeødegård, Ann‐Charlotte Iversen, Eszter Vanky   +7 more
wiley   +1 more source

The Incidence of Neonatal Herpes Simplex Virus Infections in the United States: 2019. [PDF]

Pediatrics
Pooser M, Yuan Y, Karki S, O'Callaghan K, Hufstetler K, Perez A, Berro A, Chesson H, Kreisel KM.   +8 more
europepmc   +1 more source

A Possible Role of γA-Immunoglobulin in Herpes Simplex Virus Infection in Man [PDF]

, 1966
T. Tokumaru
openalex   +1 more source

Herpes Simplex (Herpes Febrilis)

International Journal of Clinical Practice, 1965
openaire   +2 more sources

An Unusual Presentation of Herpes Zoster [PDF]

, 2020
Cristiano, Peter, Kim, Mira, Shaaban, Adnan, Tung, Robert   +3 more
core   +2 more sources

Case Report: Disseminated herpes simplex virus complicated by hemophagocytic lymphohistiocytosis in a neonate. [PDF]

Front Pediatr
Tadros N, Godiwala N.
europepmc   +1 more source

Early Events in Herpes Simplex Virus Infection: a Radioautographic Study [PDF]

, 1969
Klaus Hummeler, N Tomassini, Barbara Zając   +2 more
openalex   +1 more source

Bioactive natural products with anti‐herpes simplex virus properties

The Journal of pharmacy and pharmacology, 2015
Sherif T.S. Hassan, Radka Masarčíková, K. Berchová   +2 more
semanticscholar   +1 more source

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

Allergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller, Lawrence F. Eichenfield, Alan D. Irvine, Carsten Flohr, Andreas Wollenberg, Sébastien Barbarot, Christine Bangert, Jonathan M. Spergel, Andrew Selfridge, Pinaki Biswas, Haiyun Fan, Justine Alderfer, Melissa Watkins, Herwig Koppensteiner   +13 more
wiley   +1 more source

Clinical periodontal diagnosis

Periodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi, Andrea Roccuzzo, Jean‐Claude Imber, Alexandra Stähli, Björn Klinge, Niklaus P. Lang   +5 more
wiley   +1 more source